Ontogeny of alkaline phosphatase activity in infant intestines and breast milk
Ye Yang, Emilee Rader, Michele Peters-Carr, Rebecca C Bent, Jennifer T Smilowitz, Karen Guillemin, Bethany Rader, Ye Yang, Emilee Rader, Michele Peters-Carr, Rebecca C Bent, Jennifer T Smilowitz, Karen Guillemin, Bethany Rader
Abstract
Background: Necrotizing enterocolitis (NEC) is a devastating disease of intestinal inflammation that primarily affects premature infants. A potential risk factor for necrotizing enterocolitis is exposure of the premature neonatal intestine to environmental bacteria and their proinflammatory products such as lipopolysaccharide. The metalloenzyme alkaline phosphatase (ALP) has been shown to reduce lipopolysaccharide-mediated inflammation. Additionally, premature rat pups have reduced alkaline phosphatase activity and expression as compared to full term pups. To explore the possibility that the human premature neonatal intestine has a paucity of alkaline phosphatase activity, we measured endogenously produced intestinal alkaline phosphatase activity in meconium as a function of gestational age. To test whether breast milk could serve as a source of exogenous alkaline phosphatase to the neonatal intestine through ingestion, we measured alkaline phosphatase activity in breast milk across a range of time points post-birth.
Methods: Alkaline phosphatase activity was quantified in 122 meconium samples from infants of gestational ages ranging from 24 to 40 weeks and in 289 breast milk samples collected from 78 individual mothers between days 2-49 post-birth.
Results: We observed a strong positive correlation between the meconium alkaline phosphatase activity and gestational age, with preterm infants having lower meconium alkaline phosphatase activities than early term or term infants. Breast milk alkaline phosphatase activity was highest in the first week post-birth, with peak alkaline phosphatase activity at day 2 post-birth, followed by relatively low alkaline phosphatase activity in weeks 2-7.
Conclusions: Our results are consistent with the two major risk factors for necrotizing enterocolitis development, preterm birth and lack of breast milk feeding, both contributing to a paucity of alkaline phosphatase activity and impaired capacity to detoxify proinflammatory bacterial products such as lipopolysaccharide.
Keywords: Gestational age; LPS detoxification; Meconium; Necrotizing enterocolitis (NEC).
Conflict of interest statement
Consent for publicationThe manuscript contains no details, images or videos of any individual person.
Competing interestsThe authors declare that they have no competing interests.
Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
- Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364:255–264. doi: 10.1056/NEJMra1005408.
- MohanKumar K, Namachivayam K, Ho TTB. Torres BA. Maheshwari A. Cytokines and growth factors in the developing intestine and during necrotizing enterocolitis. Semin Perinatol: Ohls RK; 2017.
- Hall NJ, Eaton S, Pierro A. Necrotizing enterocolitis: Prevention, treatment, and outcome. J Pediatr Surg. 2013. p. 2359–67.
- Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One. 2011;6.
- Claud EC, Walker WA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J Off Publ Fed Am Soc Exp Biol. 2001;15:1398–1403.
- Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003;3:169–176. doi: 10.1038/nri1004.
- Park BS, Song DH, Kim HM, Choi B-S, Lee H, Lee J-O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009;458:1191–1195. doi: 10.1038/nature07830.
- Chan KL, Wong KF, Luk JM. Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: pathogenesis and therapeutic implications. World J Gastroenterol. 2009;15:4745–4752. doi: 10.3748/wjg.15.4745.
- Leaphart CL, Cavallo J, Gribar SC, Cetin S, Li J, Branca MF, et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol. 2007;179:4808–4820. doi: 10.4049/jimmunol.179.7.4808.
- Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA. Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res. 2001;49:589–593. doi: 10.1203/00006450-200104000-00023.
- Gribar SC, Sodhi CP, Richardson WM, Anand RJ, Gittes GK, Branca MF, et al. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol. 2009;182:636–646. doi: 10.4049/jimmunol.182.1.636.
- Morowitz MJ, Poroyko V, Caplan M, Alverdy J, Liu DC. Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics. 2010;125:777–785. doi: 10.1542/peds.2009-3149.
- Millan JL. Mammalian alkaline phosphatases: from biology to applications in Medicine and biotechnology: John Wiley & Sons; 2006.
- Tuin a, Poelstra K, de Jager-Krikken a, Bok L, Raaben W, Velders MP, et al. Role of alkaline phosphatase in colitis in man and rats. Gut. 2009;58:379–87.
- Ramasamy S, Nguyen DD, Eston MA, Nasrin Alam S, Moss AK, Ebrahimi F, et al. Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis. Inflamm Bowel Dis. 2011;17:532–542. doi: 10.1002/ibd.21377.
- Lewis ZT, Totten SM, Smilowitz JT, Popovic M, Parker E, Lemay DG, et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome BioMed Central Ltd; 2015;3:13.
- Bates JM, Akerlund J, Mittge E, Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in Zebrafish in response to the gut microbiota. Cell Host Microbe. 2007;2:371–382. doi: 10.1016/j.chom.2007.10.010.
- Rader BA, Kremer N, Apicella MA, Goldman WE, McFall-Ngai MJ. Modulation of symbiont lipid a signaling by host alkaline phosphatases in the squid-vibrio symbiosis. MBio. 2012;3.
- Lallès J-P. Intestinal alkaline phosphatase: novel functions and protective effects. Nutr Rev. 2014;72:82–94. doi: 10.1111/nure.12082.
- Biesterveld BE, Koehler SM, Heinzerling NP, Rentea RM, Fredrich K, Welak SR, et al. Intestinal alkaline phosphatase to treat necrotizing enterocolitis. J Surg Res. 2015;196:235–240. doi: 10.1016/j.jss.2015.02.030.
- Heinzerling NP, Liedel JL, Welak SR, Fredrich K, Biesterveld BE, Pritchard KA, et al. Intestinal alkaline phosphatase is protective to the preterm rat pup intestine. J Pediatr Surg. 2014;49:954–960. doi: 10.1016/j.jpedsurg.2014.01.031.
- Rentea R, Rentea M, Biesterveld B, Liedel J, Gourlay D. Factors known to influence the development of necrotizing Enterocolitis to modify expression and activity of intestinal alkaline phosphatase in a newborn neonatal rat model. Eur J Pediatr Surg.
- Chanda R. The composition of human milk with special reference to the relation between phosphorus partition and phosphatase and to the partition of certain vitamins. Br J Nutr. 1951;5:228–242. doi: 10.1079/BJN19510029.
- Karmarkar M, Ramakrishnan C. Relation between dietary fat, fat content of milk and concentration of certain enzymes in human milk. J Nutr. 1959;69:274–276. doi: 10.1093/jn/69.3.274.
- Stewart R, Platou E, Kelly V. The alkaline phosphatase content of human milk. J Biol Chem. 1958;232.
- Shahani KM, Kwan AJ, Friend BA. Role and significance of enzymes in human milk. Am J Clin Nutr. 1980;33:1861–1868. doi: 10.1093/ajcn/33.8.1861.
- Christen L, Lai CT, Hartmann B, Hartmann PE, Geddes DT. Ultraviolet-C irradiation: a novel pasteurization method for donor human Milk. PLoS One. 2013;8.
- Chatterton DEW. Nguyen DN. Bering SB: Sangild PT. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol; 2013.
- Heyndrickx G. Further investigations on the enzymes in human milk. Pediatrics. 1963;31:1019–1023.
- Worth G, Retallack R, Gutteridge D. Serum and milk alkaline phosphatase in human lactation. Clin Chim. 1981;115:171–177. doi: 10.1016/0009-8981(81)90073-5.
- Walentin S, Lévay G, Korányi L, Endroczi E. Comparative analysis of enzyme activity in human colostrum, milk, and serum. Clin Biochem. 1988;21:131–133. doi: 10.1016/S0009-9120(88)80102-4.
- Kocić G, Bjelaković L. Enzyme activity of human milk during the first month of lactation. Acta Med Austriaca. 2010;49:20–24.
- Smilowitz JT, Sullivan AOÕ, Barile D, German JB, Lo B. The human Milk Metabolome reveals diverse oligosaccharide profiles. J Nutr. 2013;143:1709–1718. doi: 10.3945/jn.113.178772.
- Totten SM, Wu LD, Parker EA, Davis JCC, Hua S, Stroble C, et al. Rapid-throughput glycomics applied to human milk oligosaccharide profiling for large human studies. Anal Bioanal Chem. 2014;406:7925–7935. doi: 10.1007/s00216-014-8261-2.
- Ziobro GC, McElroy KM. Fluorometric detection of active alkaline phosphatase and gamma-glutamyl transferase in fluid dairy products from multiple species. J Food Prot. 2013;76:892–898. doi: 10.4315/0362-028X.JFP-12-302.
- Rankin SA, Christiansen A, Lee W, Banavara DS, Lopez-Hernandez A. Invited review: the application of alkaline phosphatase assays for the validation of milk product pasteurization. J Dairy Sci. 2010;93:5538–5551. doi: 10.3168/jds.2010-3400.
- Medicine M. ACOG Committee opinion no 579: definition of term pregnancy. Obstet Gynecol. 2013;122:1139–1140. doi: 10.1097/01.AOG.0000437385.88715.4a.
- Gephart SM, McGrath JM, Effken JA, Halpern MD. Necrotizing enterocolitis risk: state of the science. Adv Neonatal Care. 2012;12:77–87. doi: 10.1097/ANC.0b013e31824cee94.
- Lallès JP. Intestinal alkaline phosphatase: Multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev. 2010. p. 323–32.
- Kumar KM, Namachivayam K, Cheng F, Jiang RHY, Flores-Torres J, Torres BA, et al. Trinitrobenzene sulfonic acid-induced intestinal injury in neonatal mice activates transcriptional networks similar to those seen in human necrotizing enterocolitis. Pediatr Res. 2017;81:99–112. doi: 10.1038/pr.2016.189.
- Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One. 2011;6.
- Torrazza RM, Ukhanova M, Wang X, Sharma R, Hudak ML, Neu J, et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS One. 2013;8.
- Warner BB, Deych E, Zhou Y, Hall-Moore C, Weinstock GM, Sodergren E, et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet (London, England). 2016;387:1928–36.
- Zhou Y, Shan G, Sodergren E, Weinstock G, Walker WA, Gregory KE. Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case-control study. PLoS One. 2015;10.
- Ramani M, Ambalavanan N. Feeding Practices and Necrotizing Enterocolitis. Clin Perinatol. 2013. p. 1–10.
- Academy A, Pediatrics OF. Milk H. Breastfeeding and the use of human Milk. Pediatr Sect Breastfeed. 2012;129:e827–e841.
- Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690–703. doi: 10.1016/j.chom.2015.04.004.
- Baro C, Giribaldi M, Arslanoglu S, Giuffrida MG, Dellavalle G, Conti A, et al. Effect of two pasteurization methods on the protein content of human milk. Front Biosci. 2011;3:818–829.
- Rochow N, Landau-Crangle E, Fusch C. Challenges in breast milk fortification for preterm infants. Curr Opin Clin Nutr Metab Care. 2015;18:276-84.
- Su BH. Optimizing nutrition in preterm infants. Pediatr Neonatol. 2014. p. 5–13.
Source: PubMed